Status:
COMPLETED
The Effect of Hyoscine-n-butylbromide on Nausea and Pain in Laparoscopic Cholecystectomy
Lead Sponsor:
Saglik Bilimleri Universitesi
Conditions:
Cholecystitis
Pain
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The goal of this randomized double blind study is to compare the effects of hyoscine-n-butylbromide, and ondansetron on postoperative nausea-vomiting, and pain in patients who underwent laparoscopic c...
Detailed Description
After obtaining the informed consent form from the patients, a total of 134 patients undergoingt laparoscopic cholecystectomy surgery will be inclueded in the study. The patients participating in the ...
Eligibility Criteria
Inclusion
- ASA score of 1-2 who undergoing laparoscopic cholecystectomy 18-65 years of age
Exclusion
- Patients who are allergic to the drugs used in the study, have an ASA score of 3-4, congestive heart failure or arrhythmia, motion sickness, central nervous system pathology, glaucoma, prostate hypertrophy, and a body mass index above 35, and used antihistamines will not included in the study
Key Trial Info
Start Date :
November 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 8 2025
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT06927817
Start Date
November 15 2020
End Date
April 8 2025
Last Update
April 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Health Sciences Fatih Sultan Mehmet Health Research and Application Center,
Istanbul, Istanbul, Turkey (Türkiye), 34668